Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting research?
Download full text from publisher
References listed on IDEAS
- Lybecker, Kristina M. & Freeman, Robert A., 2007. "Funding pharmaceutical innovation through direct tax credits," Health Economics, Policy and Law, Cambridge University Press, vol. 2(03), pages 267-284, July.
- Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,"
The Quarterly Journal of Economics,
Oxford University Press, vol. 119(3), pages 1049-1090.
- Daron Acemoglu & Joshua Linn, 2003. "Market Size in Innovation: Theory and Evidence From the Pharmaceutical Industry," NBER Working Papers 10038, National Bureau of Economic Research, Inc.
- Daron Acemoglu & Joshua Linn, 2004. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry," Levine's Working Paper Archive 228400000000000002, David K. Levine.
- Mrazek, Monique F. & Mossialos, Elias, 2003. "Stimulating pharmaceutical research and development for neglected diseases," Health Policy, Elsevier, vol. 64(1), pages 75-88, April.
- Ernst R. Berndt & Rachel Glennerster & Michael R. Kremer & Jean Lee & Ruth Levine & Georg Weizsäcker & Heidi Williams, 2007.
"Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness,"
John Wiley & Sons, Ltd., vol. 16(5), pages 491-511.
- Ernst R. Berndt & Rachel Glennerster & Michael Kremer & Jean Lee & Ruth Levine & Georg Weizsacker & Heidi Williams, 2006. "Advance Market Commitments for Vaccines Against Neglected Diseases: Estimating Costs and Effectiveness," CID Working Papers 127, Center for International Development at Harvard University.
- Frank R. Lichtenberg & Joel Waldfogel, 2003. "Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act," NBER Working Papers 9750, National Bureau of Economic Research, Inc.
- Harhoff, Dietmar & Scherer, Frederic M. & Vopel, Katrin, 2003. "Citations, family size, opposition and the value of patent rights," Research Policy, Elsevier, vol. 32(8), pages 1343-1363, September.
- Buckup, Sebastian, 2008. "Global public–private partnerships against neglected diseases: building governance structures for effective outcomes," Health Economics, Policy and Law, Cambridge University Press, vol. 3(01), pages 31-50, January.
- Michael Kremer & Heidi Williams, 2010. "Incentivizing Innovation: Adding to the Tool Kit," NBER Chapters,in: Innovation Policy and the Economy, Volume 10, pages 1-17 National Bureau of Economic Research, Inc.
- Bronwyn H. Hall & John van Reenen, 1999. "How Effective are Fiscal Incentives for R&D? A New Review of the Evidence," NBER Working Papers 7098, National Bureau of Economic Research, Inc.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
Blog mentionsAs found by EconAcademics.org, the blog aggregator for Economics research:
- How to encourage research into neglected diseases
by Economic Logician in Economic Logic on 2012-08-14 18:51:00
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- Hoddinott, John F. & Gillespie, Stuart & Yosef, Sivan, 2015. "Public-private partnerships and the reduction of undernutrition in developing countries:," IFPRI discussion papers 1487, International Food Policy Research Institute (IFPRI).
More about this item
KeywordsNeglected infectious diseases; Research and Development; push incentive mechanisms; pull incentive mechanisms;
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- L3 - Industrial Organization - - Nonprofit Organizations and Public Enterprise
- O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
NEP fieldsThis paper has been announced in the following NEP Reports:
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:40193. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Joachim Winter). General contact details of provider: http://edirc.repec.org/data/vfmunde.html .